1,320 filings
Page 13 of 66
8-K
e3n8jb ybvue6xzehf1o
11 Jun 15
Shire appoints Olivier Bohuon to its Board of Directors
12:00am
8-K
j589g8xzx
1 Jun 15
Other Events
12:00am
8-K
4fy5lcp2vvzk 026o1rt
26 May 15
Other Events
12:00am
8-K
rpvj3z883w0v
12 May 15
Other Events
12:00am
8-K
af8q uvu6363upp8vxw
5 May 15
Jeff Poulton Appointed Shire Chief Financial Officer and Joins Board of Directors
12:00am
8-K
yhs9v1wckh1g 2osg46
5 May 15
Financial Statements and Exhibits
12:00am
8-K/A
ncdrwglzu tdvr3a
1 May 15
Financial Statements and Exhibits
12:00am
8-K
g1joudcohbjutp1
30 Apr 15
Shire delivers strong revenue growth and cash generation; 20% increase in Non GAAP earnings per ADS
12:00am
8-K
3yegk149bs zx53
28 Apr 15
Results of the 2015 Annual General Meeting
12:00am
8-K
ujk614tp4slmig7x1zhg
21 Apr 15
Shire to announce first quarter 2015 results
12:00am
8-K
0v4od 5yvi8v1hn
9 Apr 15
Shire Reports Topline Results from First of Three Placebo-Controlled Phase 2 Studies of SHP625 (LUM001) in Children with Alagille Syndrome
12:00am
8-K
06cxc1s7etu 9gsiguh
9 Apr 15
U.S. FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults
12:00am
8-K
0vmxz4w6
1 Apr 15
Other Events
12:00am
8-K
7vb99i43o j0fe37
31 Mar 15
Other Events
12:00am
8-K
blnni385 9mbyxr5s
10 Mar 15
Other Events
12:00am
8-K
fjmkky
4 Mar 15
Other Events
12:00am
8-K
mp9p2o oeur86m4mv
3 Mar 15
Other Events
12:00am
8-K
k8r9yf
2 Mar 15
Other Events
12:00am
8-K
bc6j8g
25 Feb 15
Shire Completes Acquisition of NPS Pharma
12:00am
8-K
a7tjzm
13 Feb 15
Other Events
12:00am